The reduction in 24-hour, nighttime and daytime TBR < 54 mg/dl (level 2 hypoglycemia) was insignificant between the Control IQ and standard insulin therapy, these results is not comparable with the previous finding from the previous study [7]. The gene discussed is INS; the disease is Hypoglycemia.